UbiquiTx
Artificial Intelligence · Drug Discovery AI
Overview
A techbio platform that fuses AI-designed guide peptides with high-throughput multiplex screening to modulate — degrade, stabilize, or relocalize — any protein in living cells.
Funding and backers
Team
1-10
employees, estimated range
Grants
$1.6M
5 grants · CORDIS
Backers
1
E14 Fund
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 15, 2025
Won a grant $391k · CORDIS
Jul 15, 2024
Won a grant $275k · CORDIS
Jul 10, 2024
Won a grant $300k · CORDIS
Mar 1, 2024
Won a grant $313k · CORDIS
Jul 1, 2023
Won a grant $355k · CORDIS
Funding rounds
Backed byfrom the funds' portfolios and accelerator catalogs
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
E14 FundVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Programmable protein stabilization with language model-derived peptide guides
Dysregulated protein degradation via the ubiquitin-proteasomal pathway can induce numerous disease phenotypes, including cancer, neurodegeneration, and diabetes. While small molecule-based targeted protein degradation (TPD) and targeted protein stabilizat
Read more
Report
SaLT&PepPr is an interface-predicting language model for designing peptide-guided protein degraders
Protein-protein interactions (PPIs) are critical for biological processes and predicting the sites of these interactions is useful for both computational and experimental applications. We present a Structure-agnostic Language Transformer and Peptide Prior
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
New York
United States
HQ
1-10 est. staff